Corient Ia LLC Novo Nordisk A S Call Options Transaction History
Corient Ia LLC
- $141 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,805Shares Held
325MCall Options Held
11.4MPut Options Held
10.9M-
Jennison Associates LLC18.8MShares$1.28 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.05 Billion0.11% of portfolio
-
Morgan Stanley New York, NY12.2MShares$827 Million0.08% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$804 Million0.36% of portfolio
-
Loomis Sayles & CO L P11.6MShares$784 Million1.26% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $153B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...